Literature DB >> 1726119

Rapid degradation of neurotensin by stimulated rat mast cells.

D E Cochrane1, R E Carraway, W Boucher, R S Feldberg.   

Abstract

A RIA towards neurotensin (NT) using C-terminal- and N-terminal-specific antisera was used to study degradation of this tridecapeptide by isolated rat mast cells. Incubation of NT (10 microM) with peritoneal or pleural mast cells resulted in a rapid loss of NT immunoreactivity (iNT), as measured by C-terminal-directed antiserum, with little effect on N-terminal iNT. The rate of the reaction was faster with pleural cells (T1/2, 30 s) than with peritoneal cells (T1/2, 180 s) and was greater than 10-fold slower in the presence of metabolic poisons. The enzyme(s) involved is most likely released from the cells during secretion, as NT was degraded by media conditioned by compound 48/80-stimulated mast cells 40-60 times faster than by media from unstimulated cells. This degradation by conditioned media was concentration dependent, pH dependent, and temperature sensitive. HPLC analyses indicated a near stoichiometric conversion of NT to NT(1-12) (66%) and NT(1-11) (34%) after incubation for 10-30 s with conditioned media. By 30 min only NT(1-11) and NT(1-10) were present. Phenanthroline (1 mM), an inhibitor of carboxypeptidase, prevented the loss of C-terminal iNT and the generation of NT(1-12) and NT(1-11). While NT(1-12) was effective in releasing histamine from mast cells in vitro and increasing vascular permeability in vivo, NT(1-11) was not. These results suggest that carboxypeptidase-like enzyme(s) could modulate the level and form of NT-related peptides in various states involving activation of mast cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726119     DOI: 10.1016/0196-9781(91)90193-s

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  15 in total

1.  Different effects of steroidal therapy on neuropeptide-active enzymes in male and female human saliva.

Authors:  Federica Albo; Riccardo Antonangeli; Antonella Cavazza; Mario Marini; L Giorgio Roda; Paolo Rossi
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

Review 2.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

3.  Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.

Authors:  M Vasiadi; A Therianou; K D Alysandratos; A Katsarou-Katsari; T Petrakopoulou; A Theoharides; E Papadavid; N Stavrianeas; C Antoniou; D Kalogeromitros; T C Theoharides
Journal:  Br J Dermatol       Date:  2012-05-14       Impact factor: 9.302

4.  Effect of differentiation on the leucine enkephalin-degrading soluble enzymes released by the K562(S) cell line.

Authors:  M Marini; L Bongiorno; A Urbani; E Trani; L G Roda
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

5.  Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.

Authors:  Jill Donelan; William Boucher; Nikoletta Papadopoulou; Michael Lytinas; Dean Papaliodis; Paul Dobner; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

6.  Inhibitory effects of the neurotensin8-13 analogs Asp13-NT8-13 and Asp12-NT8-13 on mast cell secretion.

Authors:  L A Miller; D E Cochrane; R E Carraway; R S Feldberg
Journal:  Agents Actions       Date:  1993-01

7.  Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.

Authors:  L A Miller; D E Cochrane; R E Carraway; R S Feldberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Neurotensin is increased in serum of young children with autistic disorder.

Authors:  Asimenia Angelidou; Konstantinos Francis; Magdalini Vasiadi; Konstantinos-Dionysios Alysandratos; Bodi Zhang; Athanasios Theoharides; Lefteris Lykouras; Kyriaki Sideri; Dimitrios Kalogeromitros; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2010-08-23       Impact factor: 8.322

Review 9.  Neuroendocrinology of the skin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Alexandra Taracanova; Pio Conti; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

10.  Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Toshihiko Nishimura; Martin Metz; Eon J Rios; Paul R Dobner; Etsuko Wada; Keiji Wada; Sherma Zacharias; Uma M Mohanasundaram; James D Faix; Magnus Abrink; Gunnar Pejler; Ronald G Pearl; Mindy Tsai; Stephen J Galli
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.